Cetuximab Side Effects
Medically reviewed by Drugs.com. Last updated on Oct 19, 2024.
Applies to cetuximab: intravenous solution.
Important warnings
This medicine can cause some serious health issues
Intravenous route (solution)
Serious and potentially fatal infusion reactions may occur and require immediate interruption of the cetuximab infusion and permanent discontinuation.
Cardiopulmonary arrest and/or sudden death have been reported in patients with squamous cell carcinoma of the head and neck treated with radiation therapy and cetuximab or platinum-based therapy with 5-fluorouracil and cetuximab.
Monitoring of serum electrolytes during and after cetuximab therapy is recommended.
Precautions
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood tests may be needed to check for unwanted effects.
Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant during treatment with this medicine and for 2 months after the last dose. If you think you have become pregnant while using this medicine, tell your doctor right away.
Cetuximab may cause a serious side effect called an infusion reaction. This can be life-threatening and requires immediate medical attention. Tell your doctor or nurse right away if you have a fever, chills, trouble with breathing, lightheadedness, fainting, or chest pain within a few hours after you receive it.
Tell your doctor or nurse right away if you have a cough, difficulty with breathing, or other breathing problems while being treated with this medicine. These may be symptoms of a serious lung problem.
Serious skin reactions can occur with this medicine. Check with your doctor right away if you have blistering, peeling, or loosening of the skin, dry skin, grooves or lines in the skin, red skin lesions, severe acne or skin rash, sores or ulcers on the skin, or fever or chills while you are receiving this medicine.
This medicine may make your skin more sensitive to sunlight. Use a sunscreen or sun-blocking lotion when you are outdoors. Wear protective clothing and hats. Avoid sunlamps and tanning beds.
If you plan to have children, talk with your doctor before using this medicine. Some women using this medicine have become infertile (unable to have children).
Serious side effects of cetuximab
Along with its needed effects, cetuximab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking cetuximab:
More common side effects
- blemishes on the skin or pimples
- bloating or swelling of the face, arms, hands, lower legs, or feet
- body aches or pain
- chills
- congestion
- cough
- deep cracks, grooves, or lines in the skin
- difficult or labored breathing
- dizziness
- fever
- headache
- hoarseness
- lower back or side pain
- nausea
- painful or difficult urination
- pale skin
- rapid weight gain
- runny nose
- severe dry skin
- skin rash
- tender, swollen glands in the neck
- tightness in the chest
- tingling of the hands or feet
- trouble with breathing on exertion
- trouble with swallowing
- unusual bleeding or bruising
- unusual tiredness or weakness
- unusual weight gain or loss
- voice changes
- vomiting
Less common side effects
- anxiety
- black, tarry stools
- chest pain
- confusion
- decreased urination
- dry mouth
- fainting
- fast heartbeat
- increase in heart rate
- lightheadedness
- rapid, shallow breathing
- sore throat
- sores, ulcers, or white spots on the lips or in the mouth
- sunken eyes
- thirst
- wrinkled skin
Incidence not known
- blistering, peeling, or loosening of the skin
- cracked lips
- diarrhea
- difficulty in swallowing
- itching
- joint or muscle pain
- red, irritated eyes
- red skin lesions, often with a purple center
- stiff neck or back
Other side effects of cetuximab
Some side effects of cetuximab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- belching
- burning, dry, or itching eyes
- difficulty having a bowel movement
- discharge from the eye
- discoloration of the fingernails or toenails
- discouragement
- excessive tearing
- feeling sad or empty
- hair loss or thinning of the hair
- heartburn
- indigestion
- irritability
- lack or loss of appetite
- lack or loss of strength
- loss of interest or pleasure
- pain
- redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid
- sleeplessness
- stomach discomfort, upset, or pain
- swelling or inflammation of the mouth
- trouble concentrating
- trouble sleeping
For healthcare professionals
Applies to cetuximab: intravenous solution.
Dermatologic adverse events
- Very common (10% or more): Acneiform rash (90%), alopecia (21%), skin fissures (19%), nail disorder (16%), skin disorder (15%), acne (14%)
- Common (1% to 10%): Pruritus
- Very rare (less than 0.01%): Stevens-Johnson syndrome/toxic necrolysis
- Frequency not reported: Superinfection of skin lesions
- Postmarketing reports: Life-threatening/fatal bullous mucocutaneous disease[Ref]
Cardiovascular
- Common (1% to 10%): Cardiopulmonary arrest and/or sudden death
- Uncommon (0.1% to 1%): Deep vein thrombosis[Ref]
Gastrointestinal
- Very common (10% or more): Diarrhea (66%), nausea (55%), vomiting (41%), anorexia (36%), constipation (30%), stomatitis (26%), dyspepsia (14%), mucositis, dry mouth (12%)
- Postmarketing reports: Mucosal inflammation[Ref]
Hematologic
- Very common (10% or more): Leukopenia (25%), anemia (16%)[Ref]
Respiratory
- Very common (10% or more): Dyspnea (49%), cough (30%)
- Uncommon (0.1% to 1%): Pulmonary embolism, interstitial lung disease[Ref]
Metabolic
- Very common (10% or more): Hypomagnesemia (55%), sensory neuropathy (45%), weight loss (21%), peripheral edema (16%), dehydration (15%), severe hypomagnesemia (15%)
- Common (1% to 10%): Hypocalcemia, anorexia[Ref]
Other
- Very common (10% or more): Asthenia (56%), fever (29%), chills (16%), taste disturbance (10%)
- Common (1% to 10%): Fatigue
- Frequency not reported: Late radiation toxicity[Ref]
Ocular
- Very common (10% or more): Conjunctivitis (14%)
- Uncommon (0.1% to 1%): Blepharitis, keratitis[Ref]
Nervous system
- Very common (10% or more): Headache (19%)
- Frequency not reported: Aseptic meningitis[Ref]
Renal
- Common (1% to 10%): Kidney failure[Ref]
Hypersensitivity
- Very common (10% or more): Mild or moderate infusion related reactions
- Common (1% to 10%): Severe infusion related reactions (in some cases fatal)[Ref]
Immunologic
- Very common (10% or more): Infection (13%)
- Frequency not reported: Immunogenicity[Ref]
Musculoskeletal
- Very common (10% or more): Arthralgia (14%), back pain (16%)[Ref]
Hepatic
- Very common (10% or more): High alanine transaminase (43%), high aspartate transaminase (38%), high alkaline phosphatase (33%)[Ref]
Psychiatric
- Very common (10% or more): Insomnia (27%), confusion (18%), anxiety (14%), depression (14%)[Ref]
Local
- Very common (10% or more): Infusion reaction (e.g., chills, rigors, dyspnea, tachycardia, bronchospasm, chest tightness, swelling, urticaria, hypotension, flushing, rash, hypertension, nausea, angioedema, pain, sweating, tremors, shaking, drug fever, or other hypersensitivity reaction) (15%)[Ref]
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Bevacizumab
Bevacizumab injection is a targeted cancer drug used to treat types of non-small cell lung cancer ...
Hydroxyurea
Hydroxyurea systemic is used for cervical cancer, chronic myelogenous leukemia, glioblastoma ...
Fluorouracil
Fluorouracil systemic is used for anal cancer, breast cancer, breast cancer, palliative, cancer ...
Capecitabine
Capecitabine systemic is used for anal cancer, breast cancer, breast cancer, metastatic, colorectal ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
References
1. (2004) "Product Information. Erbitux (cetuximab)." Bristol-Myers Squibb
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. Cerner Multum, Inc. "Australian Product Information."
4. Schrag D, Chung KY, Flombaum C, Saltz L (2005) "Cetuximab therapy and symptomatic hypomagnesemia." J Natl Cancer Inst, 97, p. 1221-4
More about cetuximab
- Check interactions
- Compare alternatives
- Reviews (10)
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Cetuximab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.